re: Ann: Viralytics receives MHRA approval fo... Happy to take a short term position today. 38 or under for me. Speculation may fueled based on Cavatak results of late. Pretty impressive update and I think the general spec. bio market has missed it.
- Forums
- ASX - By Stock
- VLA
- Ann: Viralytics receives MHRA approval for UK Cli